Speaker

Christopher Ahern

Professor - Molecular Physiology & Biophysics, The University of Iowa

Christopher Ahern, Professor - Molecular Physiology & Biophysics at The University of Iowa, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Mapping Cardiac Sodium Channel Isoform Composition to Improve Ion Channel Selectivity & Reduce Arrhythmia Risk During Drug Development”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

Ion Channel-Targeted Drug Development Summit
23–24 Sept 2026Boston, United States of America

More speakers at Ion Channel-Targeted Drug Development Summit

Alejandro Amador
Vice President of R&D and Operations, Navega Therapeutics
Bruce Bean
Professor of Neurobiology, Harvard Medical School
Gulayse Dunn
Senior Principal Scientist, Novartis
Dan Elbaum
Chief Scientific Officer, QurAlis Corp.
Jim Ellis
Chief Scientific Officer, Nocion Therapeutics, Inc.
Kelly Gatfield
Group Leader & Scientific Leader, GlaxoSmithKline

See all 20 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Christopher Ahern, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].